investors

Ysios Capital

Founded 2008
Employees 15+
Primary contact
Avenida de la Libertad, 25 4th floor
20004 San Sebastian
Spain
+34 94 310 82 19
Links
https://ysioscapital.com/
Ysios Capital invests globally in biotech ventures, focusing exclusively on innovative therapeutic drugs. A leading Spanish venture capital firm, it provides private equity financing to early and mid-stage life science companies that develop disruptive therapeutic products and platform technologies.
Founded 2008
Employees 15+
Primary contact
Avenida de la Libertad, 25 4th floor
20004 San Sebastian
Spain
+34 94 310 82 19
Links
https://ysioscapital.com/

Key people 🧑‍🤝‍🧑

Investments 💸

Adcendo
A biotech company developing novel targeted anti-cancer therapies based on antibody-drug conjugates (ADCs)
📍 Copenhagen, Denmark
AM-Pharma
A biopharmaceutical company developing alkaline phosphatase (AP) as a treatment for severe inflammatory diseases
📍 Utrecht, Netherlands
Anaconda Biomed
Developer of the next generation of catheters to perform efficient mechanical thrombectomies
📍 Barcelona, Spain
CorWave
Developer of innovative implantable blood pumps based on a breakthrough membrane technology
📍 Clichy, France
MedLumics
Developer of a radiofrequency cardiac ablation catheter that allows the treatment of atrial fibrillation in real time
📍 Madrid, Spain
Splice Bio
Biotech company exploiting Protein Splicing to develop the next generation of gene therapies
📍 Barcelona, Spain
Tagworks Pharmaceuticals
Developer of click-cleavable ADC therapies for patients suffering from severe diseases, including cancer
📍 Nijmegen, Netherlands
Last update: September 17, 2022